Minervax - Crunchbase Company Profile & Funding

Q: Where is Minervax's headquarters?

Minervax is located in Hellerup, Hovedstaden, Denmark.

Q: Who invested in Minervax?

Minervax has 18 investors including Adjuvant Capital And Trill Impact.

Q: When was the last funding round for Minervax?

Minervax closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Minervax raised to date?

Minervax has raised obfuscated.

Overview

Minervax

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Minervax

CB Rank

41383

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Founded

obfuscation

Private

Venture - Series Unknown

Hellerup, Hovedstaden, Denmark

11-50

minervax.com/

Biotechnology

Health Care

Life Science

Medical

Wellness

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Debt Financing

OBF

obfuscation

Key People

Per Fischer: CEO
Past Role: Novo Nordisk, Licensing Director
Geoff Kitson: Chief Medical Officer

Details

Legal Name

Minervax ApS

Operating Status

Active

Company Type

For Profit

Founders

Per Fischer

About the Company

Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.

Contact Email

pbf@minervax.com

Predictions & Insights

Growth Insight

See this Growth Insight

Minervax is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

AlpN GBS Vaccine

A protein-based vaccine candidate targeting Group B Streptococcus, designed for maternal immunization and older adults to prevent invasive GBS infections.

AlpN GBS Monoclonal Antibodies

Monoclonal antibodies derived from AlpN GBS proteins, in early development for potential prevention or treatment of GBS infections.

Research & Development

Minervax is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Minervax	11	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Adjuvant Capital	—	Venture Round - Minervax	Kabeer Aziz
Adjuvant Capital	—	Venture Round - Minervax	Kabeer Aziz
Adjuvant Capital	—	Venture Round - Minervax	Kabeer Aziz
Adjuvant Capital	—	Venture Round - Minervax	Kabeer Aziz
Adjuvant Capital	—	Venture Round - Minervax	Kabeer Aziz